BERKELEY, Calif. and MAINZ, Germany, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the ...
Mainz Biomed N.V. has announced a partnership with Quest Diagnostics to commercialize its stool-based colorectal cancer screening test, ColoAlert, which detects tumor DNA to identify early-stage ...
This March, which is Colorectal Cancer Awareness Month, Kinney Drugs is partnering with the American Cancer Society, Upstate Cancer Center and Quest Diagnostics to provide colorectal cancer screening ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback